Supreme Court allows abortion pill to remain available by mail

The Supreme Court has ruled that patients can receive the abortion pill mifepristone through the mail without the need for an in-person appointment with a clinician. This decision follows a ruling from the 5th U.S. Circuit Court of Appeals on May 1, which had threatened to restrict access to the medication.

This development is significant as it ensures continued access to mifepristone for patients, potentially impacting reproductive health services across the United States and reaffirming the court's stance on telehealth options in abortion care.